Morse M A, Zu H, Galati A J, Schmidt C J, Stoner G D
Department of Preventive Medicine, Ohio State University, Columbus 43210.
Cancer Lett. 1993 Aug 16;72(1-2):103-10. doi: 10.1016/0304-3835(93)90018-5.
The purpose of this investigation was to establish a dose response for the effects of dietary phenethyl isothiocyanate (PEITC) on N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis and DNA methylation. Groups of 13-27 rats were randomly assigned to AIN-76A diets containing 0, 0.325, 0.75, 1.5 or 3.0 mumol PEITC/g. Two weeks later, rats were administered NMBA subcutaneously at a dose of 0.5 mg/kg once a week for 15 weeks. Animals were maintained on control or experimental diets for an additional 8 weeks and were terminated at week 25 of the experiment. No significant effects on weight gain or food intake were noted for any of the experimental diets when compared with control values. Animals receiving only NMBA developed 9.3 +/- 0.9 tumors/rat, with an incidence of 100%. Dietary PEITC at concentrations of 0.75, 1.5 and 3.0 mumol/g inhibited NMBA-induced esophageal tumor multiplicity by 39%, 90% and 100%, respectively. Esophageal tumor incidence in these groups was reduced by 0%, 40% and 100%, respectively. The 0.325 mumol/g PEITC diet did not significantly affect NMBA-induced esophageal tumorigenesis. These results indicate that the minimum inhibitory dietary concentration of PEITC is between 0.325 and 0.75 mumol/g. Groups of 20 rats were assigned to diets containing 0-3.0 mumol PEITC/g for two weeks as described above, and then sacrificed 24 hours after administration of [3H-methyl]NMBA. The esophageal DNA was isolated, purified, hydrolyzed, and analyzed by HPLC. PEITC inhibited DNA methylation in a dose-dependent manner, as was found in the tumor bioassay. The inhibition of tumor incidence was highly correlated with the percentage inhibition of either 7-methylguanine or O6-methylguanine. These latter results suggest that the inhibitory activity of PEITC in this model is manifested, at least in part, during the functional equivalent of tumor initiation.
本研究的目的是确定膳食苯乙基异硫氰酸盐(PEITC)对N-亚硝基甲基苄胺(NMBA)诱导的食管肿瘤发生及DNA甲基化作用的剂量反应。将13 - 27只大鼠分为几组,随机分配至含有0、0.325、0.75、1.5或3.0 μmol PEITC/g的AIN - 76A饮食组。两周后,大鼠皮下注射NMBA,剂量为0.5 mg/kg,每周一次,共15周。动物继续食用对照或实验饮食8周,并在实验第25周处死。与对照值相比,任何实验饮食对体重增加或食物摄入量均无显著影响。仅接受NMBA的动物每只大鼠发生9.3±0.9个肿瘤,发生率为100%。浓度为0.75、1.5和3.0 μmol/g的膳食PEITC分别使NMBA诱导的食管肿瘤多发性降低39%、90%和100%。这些组的食管肿瘤发生率分别降低了0%、40%和100%。0.325 μmol/g PEITC饮食对NMBA诱导的食管肿瘤发生无显著影响。这些结果表明,PEITC的最低抑制膳食浓度在0.325至0.75 μmol/g之间。将20只大鼠分为几组,如上所述给予含有0 - 3.0 μmol PEITC/g的饮食两周,然后在给予[³H - 甲基]NMBA 24小时后处死。分离、纯化、水解食管DNA,并通过高效液相色谱法进行分析。如在肿瘤生物测定中所发现的,PEITC以剂量依赖性方式抑制DNA甲基化。肿瘤发生率的抑制与7 - 甲基鸟嘌呤或O⁶ - 甲基鸟嘌呤的抑制百分比高度相关。后一结果表明,PEITC在该模型中的抑制活性至少部分表现在肿瘤起始的功能等效阶段。